Is it Allowed? Companies Face New Challenges with an Ever-Evolving List of “Off Limits” Ingredients in Cosmetic Products
Client Alert | 2 min read | 05.07.24
As we have previously discussed, in recent years, consumers have increasingly demanded “cleaner” beauty products and more transparency in product labeling. In addition to the FDA’s increased authority to regulate cosmetics under MoCRA, a number of states have now taken steps to regulate ingredients in cosmetics by limiting, and in some instances even banning, the use of certain ingredients that may be potentially harmful or toxic.
This web of complex and evolving regulations can be challenging for companies that manufacture and sell cosmetic products to track and follow to ensure compliance, especially when their products may be sold nationwide. Below is a May 2024 survey that may be helpful to companies in the process of untangling the current regulatory framework.
By way of background, the vast majority of states (39 of 50) have passed legislation that broadly prohibits (1) manufacturing and selling cosmetics that contain ingredients that allegedly can cause injuries and (2) providing false or misleading information on product labeling or packaging.[1]
Recent state legislation, however, goes one step beyond these regulations. As of May 1, 2024, the following states have enacted or proposed legislation limiting the manufacture, sale, and distribution of cosmetic products containing certain ingredients, including, but not limited to, chemicals like per- and polyfluoroalkyl substances (PFAS):

This recent legislation breaks down as follows:
|
ENACTED legislation banning or limiting use of PFAS in cosmetics |
PROPOSED legislation banning or limiting use of PFAS in cosmetics |
ENACTED legislation banning or limiting use of certain ingredients other than PFAS in cosmetics |
PROPOSED legislation banning or limiting use of certain ingredients other than PFAS in cosmetics |
|
|
|
|
Still unclear as to what is in and what is out? Our team has prepared a List of Banned Ingredients by State—a summary of the ingredients banned or restricted in each state, which we will monitor and update on a routine basis.
[1] States that have such legislation on the books include: Alabama, Alaska, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Vermont, Virginia, Washington, West Virginia, and Wyoming.
Contacts
Insights
Client Alert | 7 min read | 09.14.26
AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development
Over the past several years, the biopharmaceutical industry has embraced artificial intelligence and machine learning (AI/ML) in near lockstep with the pace of AI/ML innovations. Today, industry leaders are using AI/ML to, among other things: discover and assess biological pathways, target chemical structures and sequences; design proteins; model pre-clinical and clinical trials; recruit and screen potential patient populations; evaluate clinical trial results and biomarker data; prepare regulatory filings; and manage supply chains. Deployment of new AI/ML models promises extraordinary advances in pharmaceutical development. However, as with any technological and scientific advances, the use of AI/ML also poses substantial legal risks that life sciences companies need to consider and proactively manage.
Client Alert | 6 min read | 09.11.26
It’s LIVE: The Cyber Resilience Act Reporting Is Mandatory as of Today - 11 September 2026
Client Alert | 10 min read | 09.11.26
Mining, Indigenous Consultation Rights, and Investment Treaty Protection
Client Alert | 2 min read | 09.11.26
New ISOO Guidance Directs Federal Agencies to Provide More CUI Guidance to Contractors



